Pfizer Inc
Change company Symbol lookup
Select an option...
PFE Pfizer Inc
CVX Chevron Corp
ACGLO Arch Capital Group Ltd
AAPL Apple Inc
BCSF Bain Capital Specialty Finance Inc
HPE Hewlett Packard Enterprise Co
CCRN Cross Country Healthcare Inc
WEJO Wejo Group Ltd
AZYO Aziyo Biologics Inc
AMED Amedisys Inc
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operates through two segments: Biopharma and PC1. Biopharma is engaged in the science-based biopharmaceutical business. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. The Company’s primary care products include Eliquis, Nurtec ODT/Vydura and the Premarin family; the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac and Trumenba; Comirnaty, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Eucrisa/Staquis and Cibinqo; the Vyndaqel family, Oxbryta, BeneFIX and Genotropin, and Sulperazon, Medrol, Zavicefta, Zithromax, Vfend and Panzyga. Its oncology products include Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena and Braftovi.

Premarket

Last Trade
Delayed
$38.81
Change Since Close

Change Since Close

Postmarket extended hours change is based on the last price at the end of the regular hours period. Premarket extended hours change is based on the day's regular session close.

0.45 (1.17%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$38.36
Day's Change
-0.29 (-0.75%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
11,223

10-day average volume:
37,810,560
11,223
Historical quotes & splits

McCormick & Co. Inc. Stock Rises Monday, Outperforms Market

5:11 pm ET March 13, 2023 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of McCormick & Co. Inc. (MKC) rallied 1.65% to $72.12 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.15% to 3,855.76 and Dow Jones Industrial Average falling 0.28% to 31,819.14. The stock's rise snapped a two-day losing streak. McCormick & Co. Inc. closed $33.07 below its 52-week high ($105.19), which the company achieved on April 21st.

Trading volume (1.5 M) eclipsed its 50-day average volume of 1.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled March 13, 2023.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

March 13, 2023 17:11 ET (21:11 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.

3rd Party Research Disclosure